CFD
UTHR icon

Creative Financial Designs’s United Therapeutics UTHR Stock Holding History

Creative Financial Designs’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Buy
+2
New +$996 ﹤0.01% 1863
2019
Q1 		– Sell
-33
Closed -$4K – 653
2018
Q4 		$4K Sell
33
-34
-51% -$3.94K ﹤0.01% 463
2018
Q3 		$9K Sell
67
-81
-55% -$10K 0.01% 453
2018
Q2 		$17K Buy
+148
New +$16.3K 0.01% 386

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Creative Financial Designs's UTHR Position: Q1 2026 in Review

Creative Financial Designs opened a new position in United Therapeutics (UTHR) in Q1 2026: 2 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #1863 among its holdings. This is a return to the name: Creative Financial Designs previously reported a position in UTHR as recently as Q4 2018.

Creative Financial Designs first reported a position in UTHR in Q2 2018 and has held it in 4 quarters since. The position peaked at $17K in Q2 2018. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Creative Financial Designs held 2 shares of United Therapeutics worth $1.19K as of Q1 2026.
  • United Therapeutics was a new Creative Financial Designs position in Q1 2026.
  • United Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1863 holding.
  • Creative Financial Designs first reported a position in United Therapeutics in Q2 2018 and has held it in 4 quarters since.
  • Creative Financial Designs's United Therapeutics position peaked at $17K in Q2 2018.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.